Member Info for MattTheBrave

Greencoat renewables invests in a diversified portfolio of wind and solar projects across Europe denominated in Euros.
UK Wind - well, I think the name of the fund gives the game away on that one!
Greencoat is the investment manager on both funds, siourcing and managing the opportunities.

two things:
1. Ridiculous response from the market for such a small issue
2. Management has been badly advised regarding these issues. Better to do one large one and then tel the market no more for 5 years. Also, discount too big - why did the feel need to price it so much lower than the price a few days before.
Whole thing shoddily handled, followed by market over-reaction. Annoying.

Ouch!!

Yep, all looks good here. I've let a few of these go now, but still have a decent position. Fair value up at 1.90 to £2 IMV.

Steady as she goes with a decent order book. Difficult to say the stock is cheap on 20x this years' earnings, but certainly well supported by the fundamentals at these levels. Let's hope this management doesn't F it up like the last lot.......:-0

Please read my posts more closely Prussell. I did not say that price and value were the the same thing. I said that Cheap and Value were. Vlaue managers always look to buy Cheap stocks.

GS - We dod disagree on one thing - AV will not and should not be at the same valuation as L&G - it is a significantly inferior company IMV . I think 10x is fine for AV (nearly 50% increse in valn) but I think L&G should be above 12x (20% up). So both are undervalued here, but AV more so.

*cann = cannot. I really must get into the habit of re-reading stuff before posting!!

Davy - for the love of God, I know you love this stock, butit seems to me you have too much of your wealth tied up in a stock where the outcome cann be fully predicted by anyone, no matter how good they are. Why don't you diversify, and guartantee some better nights' of sleep.

I have no more than 1% of my total wealth in any one particular stock which certainly helps the old blood pressure!!

The issue is for less than 5% of the current market cap, so relatively modest in the scheme of things. Presumably all the sellers are hoping to but back cheaper in the issue. If it's oversubscribed (and I suspet it will be) it will recover quickly as those who sold too many try and but back in!

A few more observations from me if I may:
- 'Cheap' and 'value' are the same thing for me so I don't really unserstand your first point
- 'Tipsters' offer no added value in my view. they knoiw no more tha you and I, and invariably jump on band wagons late. I find that fact that there are no tipsters for AV a positive, as it means there's plenty of upside change potentiial. It was exactly the same in LGEN 4 years ago when I built my position there.
- We can always look at other shares in himndsight and identify thosethat would have made us loads of money, but that's a damaging and unhelpful approach. Ignore past performance as much as you can, think about the long term fundamentals of the business, and how the market is valuing this and invest accordingly. If your thesis is correct, other investors will always wake up at some point. Aviva on 7x this years earnings versus L&G on 10x means both are worth holding here IMV

They're fine, and in line with direction given a few monthe back. Clearly the 2nd half was slower than might have been expected given H1 signs, but certainly not disastrous by any means. Skeletor is wrong about the dividend though - eps of 22p, divvy of 13 p, so clearly covered. I think EPS for the full year will be in the high 40s as well, so covering the 43p.

Taking a bit longer than I thought. Still - better late than never!!

Firstlty DC - Not sure you understand how stock markets work. Buyes always equals sellers - it's the price which changes to clear the market (ie bring buyers and sellers together). And if you're going on the 'buys' and 'seels' on this Board, you even more misgudided than I thought - they are call them a buy or sell based on whether they are nearer to the bid or the offer - they are effectively meaningless.

Prussell - stupid to focus on short term technical factors, or guessing what other investors will do at diffeerent price levels. What we know is the current prices is where buyers = sellers. You take a view as to whether this is overvalued or undervalued, and then invest accordingly. Housebuilding is horrible - highly cyclical, extremely capital intensive, significant political risks etc etc. They're cheap because they should be.

Jesus Brad, you really did invest in load of junk. I'd stick to index funds from now on if I were you......

Goldenshares, my Caver colleague - we are in agreement on this one. Both LGEN and AV worth holding, but AV the cheaper relative play currently.

I quite like boring stocks - means the market has lost faith or isn't looking at them. this is what creates undervaluation and future performance potential. I think Aviva could wee attract some bid interest in the next 12-18months. We'll see.

Clear facts of the matter are that Aviva is a vastly inferior company to L&G. No decent asset management business, late into the fast growing annuity business, too focused on low returning genral insurance, poor and changing management. This is why I've been in L&G for 4 years or so. However , as L&G climbed up towards 320p, the market was finally starting to price this in (1x book versus more than 2x at L&G) and hence I shifted one-third of my L&G position into Aviva. Aviva has certainly 'failed' on a relative basis as with L&G, you would have got 50% share price appreciation as well as substantial dividends, but based on the relative valuations, I'm happy to hold both here.

...at 279p. Good and continuing growth, falling capital intensity, and a falling to a PE of nearly 10x 2021. Also, cash on the balance sheet which is always nice to see for a smaller Company. Nice pick up today, though can't find why. Anyone know?

...since April 2015 when the the stock price was £8. Rating does discount some good news, but the real key medium-term is the success of Siemen's high sensitivityTroponin cardiac test. I'm happy to keep running with this highly cash generative stock for now, but if it hit £45 in the first half of this year, I'de look to reduce.

Thanks Task - yes, looks like one last sting in the tail of PPI!